Chinese herbal medicine for symptom management in cancer palliative care systematic review and meta-analysis

Medicine (United States)

Volumn 95, Issue 7, 2016, Pages e2793-

  Chung, Vincent C H ^a   Wu, Xinyin ^a   Lu, Ping ^a   Hui, Edwin P ^a   Zhang, Yan ^b,c   Zhang, Anthony L ^c,d   Lau, Alexander Y L ^a   Zhao, Junkai ^a   Fan, Min ^a   Ziea, Eric T C ^a,e   Ng, Bacon F L ^e   Wong, Samuel Y S ^a   Wu, Justin C Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TEXAS TECH UNIVERSITY   (United States)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d RMIT UNIVERSITY   (Australia)

^e HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CHINESE MEDICINE; CHRONIC PAIN; CONSTIPATION; DATA BASE; DYSESTHESIA; FATIGUE; HUMAN; INSOMNIA; META ANALYSIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PARESTHESIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; COMPLICATION; NEOPLASMS; PAIN; PALLIATIVE THERAPY; PHYTOTHERAPY;

HERBACEOUS AGENT;

ANOREXIA; CONSTIPATION; DRUGS, CHINESE HERBAL; FATIGUE; HUMANS; NEOPLASMS; PAIN; PALLIATIVE CARE; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84959120023     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002793     Document Type: Review

References (52)

1. The Lancet. Moving cancer up the global health agenda. The Lancet. 2010;375:2051.
2. Stark L, Tofthagen C, Visovsky C, et al. The symptom experience of patients with cancer. J Hosp Palliat Nurs. 2012;14:61-70.
3. Deshields TL, Potter P, Olsen S, et al. Documenting the symptom experience of cancer patients. J Support Oncol. 2011;9:216-223.
4. Pachman DR, Barton DL, Swetz KM, et al. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30:3687-3696.
5. Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care-Part II: cachexia/anorexia and fatigue. J Palliat Med. 2006;9:409-421.
6. Queiroz G, Santos A, Pereira R, et al. Prevalence of paresthesia, fatigue, edema and pain after treatment for breast cancer. Appl Cancer Res. 2009;29:173-178.
7. Pujol LA, Monti DA. Managing cancer pain with nonpharmacologic and complementary therapies. J Am Osteopath Assoc. 2007;107(12 suppl 7):Es15-Es21.
8. Bruera E. Clinical management of anorexia and cachexia in patients with advanced cancer. Oncology. 1992;49(suppl 2):35-42.
9. Perdue C. Managing constipation in advanced cancer care. Nursing Times. 2005;101:36-40.
10. Bruera E, Yennurajalingam S. Palliative care: Overview of fatigue, weakness, and asthenia. 2015; http://www.uptodate.com/contents/palliative-care-overview-of-fatigue-weakness-and-asthenia?sour-ce14;machineLearning&search14;fatigue&selectedTitle14;2-150§i-14;2-150§ionRank14;4&anchor14;H29611194#H29611194. Accessed 12 March, 2015.
11. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289-305.
12. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573-581.
13. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA. 1995;274:1870-1873.
14. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. New Engl J Med. 1994;330:592-596.
15. Loprinzi CL, Ellison NM, Schaid DJ, et al. Controlled trial of megestrol-acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer I. 1990;82:1127-1132.
16. Willox JC, Corr J, Shaw J, et al. Prednisolone as an appetite stimulant in patients with cancer. Brit Med J. 1984;288:27-127.
17. Jatoi A, Kumar S, Sloan JA, et al. On appetite and its loss. J Clin Oncol. 2000;18:2930-2932.
18. Paltiel O, Marzec-Boguslawska A, Soskolne V, et al. Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life. Qual Life Res. 2004;13:1699-1706.
19. Jin X, Julieta RB, Sze DM, et al. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2012;6:CD007731.
20. Su R, Li L, Xu H-B, et al. A systematic review of therapeutic efficacy and safety of adjuvant therapy of compound sophora flavescens injection in the treatment of tumor [Chinese]. China Pharma. 2013;24:4154-4163.
21. Fu J, Yu J, Xu H-B, et al. Systematic evaluation about efficiency detoxification of Chinese traditional medicine adjuvant chemotherapy for solid tumors [Chinese]. Guiding J Tradit Chin Med Pharma. 2010;16:108-112.
22. Molassiotis A, Potrata B, Cheng KKF. A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients. Complement Ther Med. 2009;17:92-120.
23. Caraceni A, Cherny N, Fainsinger R, et al. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manage. 2002;23:239-255.
24. Yang D, Zhong-zhi Q, Yan-ze L, et al. New Collection of Crude Drugs in Chinese Pharmacopoeia 2010 I. Callicarpa Linn. and Related Items. Chin Herb Med. 2010;02:272-288.
25. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. Vol. 3302005.
26. Wong SSL, Wilczynski NL, Haynes RB. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. J Med Lib Assoc. 2006;94:41-47.
27. Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Vol. 3432011.
28. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Vol. 3272003.
29. Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. Vol. 3422011.
30. Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. www.cochrane-handbook.org.
31. Zhao WH, Su ZX, Cao XM, et al. The effect of Qing-Shu Particles in the Treatment on Constipation resulted from Chemotherapy to the Lymphoma Patients [Article in Chinese]. Modern Oncol. 2006;14:1286-1287.
32. Gao YL, Li LY, Li PW. Clinical study on the effectiveness of Yi-Qi-Run-Chang Method for opioids induced constipation [Article in Chinese]. J Trad Chin Med Emergency. 2010;19:585-586.
33. Gui L, Liu YX, Ma HR, et al. Effictiveness of modified Bu-Zhong-Yi-Qi decoction for chemotherapy induced constipation among colorectal cancer patients [Article in Chinese]. China Pharma. 2010;21:2574-2575.
34. Li ZM, Dong QH, Chen GF, et al. Clinical observation on the effectiveness of Jia-Wei-Ji-Chuan-Jian Clyster for constipation on cancer patients [Ariticle in Chinese]. J New Chin Med. 2011;43: 100-101.
35. Lin HF, Wu X, Lin XM. Chinese herbal medicine retention clyster for constipation in 35 patients with advanced cancer [Ariticle in Chinese]. Fujian J TCM. 2011;42:41.
36. Zhao JY, Sun MF. The obserbation of improved increasing liquid Tong-ga Minus Clyster in the treatment of opioids induced constipation [Ariticle in Chinese]. China Modern Doctor. 2013;51:119-121.
37. Zhang LL, Chen L, Jia YT, et al. The effect of Fu-zheng-he-ji to the quality of life on patients with recurrent or metastatic breast cancer. J Pract Trad Chin Int Med. 2009;23:35-36.
38. Sun H, Li ZD, Wang W, et al. A randomized controlled trial on Ren-shen-yang-rong decoction for improving fatigue in cancer patients who are receiving chemotherapy [Article in Chinese]. Chin J Basic Med in Trad Chin Med. 2010;16:155-157.
39. Huang ZF, Wei JS, Yuan Y, et al. Effect of Jian-pi-xiao-ji decoction on quality of life in patients with cancer related fatigue [Article in Chinese]. World Chin Med. 2012;7:481-483.
40. Wang SW. Clinical Observation of the Efficacy of Tong-tai Decoction in Combination with XELOX Regimen Chemotherapy for Treating Advanced Colorectal Cancer [Article in Chinese]. Nanjing, China: Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine; 2012.
41. Ju SB, Zou YH. Effectiveness on Jia-Wei-Xiang-Sha-Liu-Jun-Zi decoction plus Fentanyl Transdermal Patch for cancer related pain in 60 advance cancer patients [Ariticle in Chinese]. New J Trad Chin Med. 2006;38:55-56.
42. Jiang GS, Zhang G, Ren WD. The combination of traditional Chinese medicine and Western medicine for advanced colorectal cancer. Chin J Experiment Trad Med Formulae. 2013;19:323-325.
43. Fu DZ. Improvement of anorexia and weight reducing in patients with lung cancer by integrated Chinese and Western medicine [Article in Chinese]. Zhejiang Journal of Intergrative Traditional Chinese and Western Medicine. 2006;16:471-472.
44. Wu XD, Zheng NY, Xu LQ, et al. Clinical observation on the combination of Gui-Dan-San-Zi-San-Re-Wei and Hyperthermia, radiotherapy for treating pain in cancer patients with bone metastases [Article in Chinese]. J New Chin Med. 2011;43:102-103.
45. Qi F, Li A, Inagaki Y, et al. Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer. Biosci Trends. 2010;4:297-307.
46. Xu L, Lao LX, Ge A, et al. Chinese herbal medicine for cancer pain. Integr Cancer Therap. 2007;6:208-234.
47. Schaffer D, Florin T, Eagle C, et al. Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review. Med J Aust. 2006;185:501-506.
48. Koornstra RHT, Peters M, Donofrio S, et al. Management of fatigue in patients with cancer-A practical overview. Cancer Treat Rev. 2014;40:791-799.
49. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials (Chinese version). J Chin Integr Med. 2010;8:701-741.
50. Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336:601-605.
51. Savović J, Jones HE, Altman DG, et al. Influence of reported study design characteristics on intervention effect estimates from Randomized, controlled trials. Ann Intern Med. 2012;157: 429-438.
52. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726-732.